Lake Forest, IL, United States of America

Anwer Basha

This inventor holds 23 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in CNS Active Agents. Top assignee: Abbott Laboratories Corporation. Active years: 1990-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anwer Basha. Retrieved from https://idiyas.com/inventor/anwer-basha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 1)

% Patents Active = 78.3

CIPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 154(Granted Patents)

Company Filing History:

23 out of 4,190

Abbott Laboratories Corporation

patents

Years Active: 1990-2012

Loading Chart...

Areas of Expertise:

CNS Active Agents

Lipoxygenase Inhibitors

Prostaglandin Inhibitors

Diazabicyclic Compounds

Hydroxyurea Derivatives

Pyran Derivatives

Arylalkynyl Compounds

Thienyl Alkynyl Compounds

Polyether Lignan Lactones

Triazinone Compounds

Pyrimido-Pyrimidine Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8119635 - Diazabicyclic central nervous system active agents (2012-02-21),

2. 7598236 - Diazabicyclic central nervous system active agents (2009-10-06),

3. 7319106 - Diazabicyclic central nervous system active agents (2008-01-15),

4. 7115591 - Prostaglandin endoperoxide H synthase biosynthesis inhibitors (2006-10-03),

5. 7001895 - Prostaglandin endoperoxide H synthase biosynthesis inhibitors (2006-02-21),

6. 6809105 - Diazabicyclic central nervous system active agents (2004-10-26),

7. 6307047 - Prostaglandin endoperoxide H synthase biosynthesis inhibitors (2001-10-23),

8. 5616596 - Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of (1997-04-01),

9. 5559144 - Furyl and thienyl alkynyl-N-hydroxy urea derivatives (1996-09-24),

10. 5516789 - Lipoxygenase and cyclooxygenase inhibiting compounds (1996-05-14),

11. 5484786 - Pyran-4-ylmethyl substituted arylalkylaryl-, arylalkenylylaryl-, and (1996-01-16),

12. 5476873 - Acetylene derivatives having lipoxygenase inhibitory activity (1995-12-19),

13. 5446062 - ((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and (1995-08-29),

14. 5446055 - Polyether naphthalenic lignan lactones as inhibitors of 5-lipoxygenase (1995-08-29),

15. 5432194 - (4-alkoxypyran-4-yl) substituted arylalkylaryl-, aryalkenylaryl-, and (1995-07-11),

Certainly! Here is an article about inventor Anwer Basha:

Title: The Innovative Journey of Anwer Basha

Introduction: Anwer Basha, a prolific inventor based in Lake Forest, IL (US), has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions.

Latest Patents: Anwer Basha holds an impressive total of 23 patents, with his latest innovations involving Diazabicyclic central nervous system active agents. These compounds and pharmaceutical compositions have revolutionized the control of synaptic transmission in mammals.

Career Highlights: Working at Abbott Laboratories Corporation, Anwer Basha has demonstrated a remarkable dedication to advancing science and medicine. His patented inventions have not only pushed the boundaries of pharmaceutical research but have also paved the way for new treatment modalities.

Collaborations: Throughout his career, Anwer Basha has collaborated with esteemed colleagues such as Andrew O Stewart and Lawrence A Black. Together, they have synergized their expertise to bring forth cutting-edge solutions in the pharmaceutical industry.

Conclusion: Anwer Basha's exceptional work ethic, coupled with his innovative mindset, has established him as a trailblazer in the realm of pharmaceutical inventions. His patents stand as a testament to his relentless pursuit of scientific excellence and commitment to improving healthcare outcomes.

I hope this article provides a comprehensive overview of Anwer Basha's remarkable achievements in the world of innovations and inventions. If you have any more specific requests or need further information, feel free to let me know!

Profile summary based on public USPTO records.